ResearcherThe University of OsakaActive in the last 2 years
Shotaro Tatekawa
Matched on ORCID iD 0000-0002-7504-859X; OpenAlex author ID A5016365832. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2022: 3 papers · 2023: none · 2024: 2 papers
Papers 5
- High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. Co-author DOI 10.1111/cas.16152↗
- Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review). Co-author DOI 10.3892/ol.2024.14247↗
- Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. Co-author DOI 10.1016/j.isci.2022.104659↗
- N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-022-15196-5↗
- Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fphys.2022.1025923↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuhiko Ogawa · 5 shared papers, 2022–2024 · strength 0.76
- Paper Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review). DOI 10.3892/ol.2024.14247↗
- Paper High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. DOI 10.1111/cas.16152↗
- Paper Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. DOI 10.3389/fphys.2022.1025923↗
- Hideshi Ishii · 5 shared papers, 2022–2024 · strength 0.76
- Paper Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review). DOI 10.3892/ol.2024.14247↗
- Paper High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. DOI 10.1111/cas.16152↗
- Paper Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. DOI 10.3389/fphys.2022.1025923↗
- Yuichiro Doki · 4 shared papers, 2022–2024 · strength 0.55
- Paper High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. DOI 10.1111/cas.16152↗
- Paper Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. DOI 10.3389/fphys.2022.1025923↗
- Paper N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiother… DOI 10.1038/s41598-022-15196-5↗
- Hidetoshi Eguchi · 4 shared papers, 2022–2024 · strength 0.55
- Paper High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. DOI 10.1111/cas.16152↗
- Paper Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. DOI 10.3389/fphys.2022.1025923↗
- Paper N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiother… DOI 10.1038/s41598-022-15196-5↗
- Tomoaki Hara · 3 shared papers, 2022–2024 · strength 0.51
- Paper Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review). DOI 10.3892/ol.2024.14247↗
- Paper High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. DOI 10.1111/cas.16152↗
- Paper Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. DOI 10.3389/fphys.2022.1025923↗
- Hiromichi Sato · 3 shared papers, 2022–2024 · strength 0.51
- Paper Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review). DOI 10.3892/ol.2024.14247↗
- Paper High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. DOI 10.1111/cas.16152↗
- Paper Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. DOI 10.3389/fphys.2022.1025923↗
- Kazuki Sasaki · 3 shared papers, 2022–2024 · strength 0.42
- Paper High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. DOI 10.1111/cas.16152↗
- Paper Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma. DOI 10.3389/fphys.2022.1025923↗
- Paper Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. DOI 10.1016/j.isci.2022.104659↗
- Yoshiko Tsuji · 2 shared papers, 2024 · strength 0.36
- Sikun Meng · 2 shared papers, 2024 · strength 0.36
- Yu Takeda · 2 shared papers, 2022–2024 · strength 0.27
- Daisaku Yamada · 2 shared papers, 2022–2024 · strength 0.27
- Hidenori Takahashi · 2 shared papers, 2022–2024 · strength 0.27
- Ryota Chijimatsu · 2 shared papers, 2022 · strength 0.25
- Suguru Mitsufuji · 1 shared paper, 2022 · strength 0.14
- Hirofumi Akita · 1 shared paper, 2022 · strength 0.14
- Yoshiki Murakumo · 1 shared paper, 2022 · strength 0.14
- Yoshito Tomimaru · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.